However, human clinical evidence is still limited, and larger, well-controlled trials are needed to clarify safety, efficacy, and appropriate use
TB-500: The Inflammation Controller TB-500 is a synthetic fragment of thymosin beta-4, a peptide naturally produced by the thymus gland
Unknown long-term effects of injectable use: There simply isn't long-term safety data for subcutaneous GHK-Cu used repeatedly over years
HIV/AIDS, Alzheimers, Parkinsons disease, asthma, different cancers, cataracts, macular degeneration, open angle glaucoma, diabetes, and many diseases of the liver, kidneys, lungs, and digestive system
M., Al-Foheidi, M